Prime Medicine Inc (PRME)
7.085
+0.04
(+0.64%)
USD |
NASDAQ |
May 17, 16:00
7.085
0.00 (0.00%)
After-Hours: 20:00
Prime Medicine Total Liabilities (Quarterly): 67.62M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 67.62M |
| December 31, 2023 | 60.78M |
| September 30, 2023 | 45.19M |
| June 30, 2023 | 40.76M |
| March 31, 2023 | 38.14M |
| Date | Value |
|---|---|
| December 31, 2022 | 44.04M |
| September 30, 2022 | 42.56M |
| June 30, 2022 | 46.86M |
| December 31, 2021 | 62.30M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
38.14M
Minimum
Mar 2023
67.62M
Maximum
Mar 2024
49.81M
Average
45.19M
Median
Sep 2023
Total Liabilities (Quarterly) Benchmarks
| Pacific Biosciences of California Inc | 1.021B |
| 10x Genomics Inc | 204.08M |
| Recursion Pharmaceuticals Inc | 156.70M |
| Verve Therapeutics Inc | 149.29M |
| Ginkgo Bioworks Holdings Inc | 594.49M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 311.38M |
| Shareholders Equity (Quarterly) | 243.77M |
| Current Ratio | 8.905 |